Aequus BioPharma,a subsidiary of Cell Therapeutics,has named Ronald Berenson as the company's new president and CEO. Prior to joining the company,Berenson served as president and CEO at HemaQuest Pharmaceuticals and as ...
Tags: Aequus BioPharma, Cell Therapeutics, CEO, Ronald Berenson
Galena Biopharma and Leica Biosystems have joined forces to develop a companion diagnostic for Galena's NeuVax(nelipepimut-S or E75),a breast cancer therapeutic. As part of the partnership,Leica's Bond Oracle HER2 IHC System companion ...
Aerial BioPharma, a biopharmaceutical company, has won FDA orphan drug designation for its narcolepsy drug in development. The issuance of designation from the FDA follows the completion of a Phase IIa study in which N05 demonstrated ...
Relay Technology Management (Relay TM) has introduced Business Development Live (BD Live!), a new unified, real-time data visualization, comparative asset analysis and tracking platform for the life sciences industry. BD Live! enables ...
Tags: Relay TM, Relay Technology Management, real-time data visualization
Quintiles and Allscripts have partnered to jointly develop software solutions for clinical and post-approval research. The collaboration focuses on late-phase research, recruiting for and monitoring of clinical trials, and post-market ...
Tags: Quintiles, software solutions for clinical, Allscripts
PDL BioPharma has reported a net income of $48.57m, or $0.32 per diluted share, for the third quarter ended 30 September 2012 compared to $45.92m, or $0.28 per diluted share, for the third quarter ended 30 September 2011. Total revenues ...
Tags: PDL BioPharma, royalty revenues, PDL
Galena Biopharma has reported a net loss of $6.26m, or $0.09 per share, for the third quarter ended 30 September 2012 compared to a net loss of $5.47m, or $0.09 per share, for the third quarter ended 30 September 2011. Operating loss for ...
Tags: Net Loss, operational and business development, patient enrollment
S1 Biopharma, an early-stage biopharmaceutical company, has announced its foray into male sexual health with S1P-205, the drug in development to treat Hypoactive Sexual Desire Disorder (HSDD) in males. With the development of S1P-205, the ...
Tags: S1 Biopharma, male sexual health, S1P-205, drug
Hemispherx Biopharma has filed an amended NDA with ANMAT (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica) for the use of Alferon N injection to treat Hepatitis C patients in Argentina. ANMAT has previously approved ...
Tags: Hemispherx Biopharma, Amended NDA, Alferon N Injection, ANMAT
Specialty chemicals manufacturer BASF has offered to acquire Pronova BioPharma, which manufactures omega-3 fatty acids. As part of the acquisition plan, BASF has signed an agreement with Pronova to suggest voluntary public takeover offer ...
Ten biopharmaceutical companies, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi have established a non-profit organization ...
Tags: biopharmaceutical companies, non-profit organization, new medicines
The Kedrion Group, a developer of plasma derived products, has purchased Ortho-Clinical Diagnostics' Rho(D) immune globulin (Human) RhoGAM and Rho(D) Immune Globulin (Human) MICRhoGAM ultra-filtered Plus products, used for the prevention of ...
Tags: plasma derived products, Immune Globulin, ultra-filtered Plus products
The US Patent and Trademark Office (USPTO) has issued a key patent covering the use of Galena Biopharma's NeuVax for inducing immunity to breast cancer recurrence in patients having low-to-intermediate IHC levels of 1+ or 2+ and a FISH ...